Literature DB >> 11767027

Effect of sildenafil on ocular haemodynamics.

S O Dündar1, M Dündar, I Koçak, Y Dayanir, S B Ozkan.   

Abstract

PURPOSE: To study the effect of sildenafil, which is an effective agent for the treatment of erectile dysfunction, on ocular haemodynamics.
METHODS: In this prospective study we examined the effect of a single oral dose of 50 mg sildenafil (Viagra) in a group of healthy young male volunteers, by using colour Doppler ultrasound imaging to measure haemodynamic variables in the central retinal artery (CRA), short temporal posterior ciliary artery (STPCA) and ophthalmic artery (OA). The following examinations were performed on both eyes immediately before and 1 h after a single oral dose of 50 mg sildenafil: visual acuity, intraocular pressure (IOP), colour vision, anterior segment, fundus appearance, resting heart rate, blood pressure and colour Doppler measurements.
RESULTS: After sildenafil administration, peak systolic velocity, mean velocity and end-diastolic velocity significantly increased in the OA of both eyes. All Dopper indices remained non-significant for the CRA and STPCA of both eyes. Sildenafil did not cause any significant change in IOP, colour vision, visual acuity, systolic blood pressure or diastolic blood pressure. However, heart rate measurements increased significantly after sildenafil administration compared with baseline (p = 0.003).
CONCLUSION: The increased flow velocity in the ophthalmic artery seems to be due to a vasodilator effect of sildenafil.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11767027     DOI: 10.1038/eye.2001.163

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  10 in total

1.  Measurement of choroidal perfusion and thickness following systemic sildenafil (Viagra(®) ).

Authors:  David Y Kim; Ronald H Silverman; Robison Vernon Paul Chan; Aziz A Khanifar; Mark Rondeau; Harriet Lloyd; Peter Schlegel; Donald Jackson Coleman
Journal:  Acta Ophthalmol       Date:  2012-09-13       Impact factor: 3.761

Review 2.  New treatment options for erectile dysfunction in patients with diabetes mellitus.

Authors:  Ansu Basu; Robert E J Ryder
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 3.  Precautions and Monitoring of Patients Taking Phosphodiesterase Type 5 Inhibitors Who are at Risk of Increased Intraocular Pressure.

Authors:  Joshua C Baker; Robert Fintelmann; Roohollah Sharifi; Mary Lee
Journal:  Drugs Aging       Date:  2019-11       Impact factor: 3.923

4.  Effects of orally administered moxaverine on ocular blood flow in healthy subjects.

Authors:  Doreen Schmidl; Berthold Pemp; Michael Lasta; Agnes Boltz; Semira Kaya; Stefan Palkovits; Franz Prager; Leopold Schmetterer; Gerhard Garhofer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-12-01       Impact factor: 3.117

5.  Ocular toxicity assessment of chronic sildenafil therapy for pulmonary arterial hypertension.

Authors:  Licia Matieli; Adriana Berezovsky; Solange Rios Salomão; Norma Allemann; Elisabeth Nogueira Martins; Flavio E Hirai; Jaquelina Ota-Arakaki; Maira S A Morales; Denise de Freitas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-04-19       Impact factor: 3.117

Review 6.  Phosphodiesterase Type 5 Inhibitors and Visual Side Effects: A Narrative Review.

Authors:  Francisco Barroso; João Crispim Ribeiro; Eduardo P Miranda
Journal:  J Ophthalmic Vis Res       Date:  2021-04-29

7.  Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III, randomised, double masked, placebo controlled trial and open label extension.

Authors:  Barbara M Wirostko; Charles Tressler; Lie-Ju Hwang; Gary Burgess; Alan M Laties
Journal:  BMJ       Date:  2012-02-21

8.  Long-term follow-up of retinal morphology and physiology after 2000 mg sildenafil overdose as a means of attempted suicide: a case report.

Authors:  Gen Miura; Takayuki Baba; Ryusuke Hashimoto; Shuichi Yamamoto
Journal:  BMC Ophthalmol       Date:  2022-05-12       Impact factor: 2.086

9.  Sildenafil dilates ophthalmic artery in type 2 diabetic patients.

Authors:  Akeel Amh Zwain; Najah R Hadi; Ahmed M Al-Mudhaffer
Journal:  SAGE Open Med       Date:  2013-08-20

Review 10.  Visual Side Effects Linked to Sildenafil Consumption: An Update.

Authors:  Eva Ausó; Violeta Gómez-Vicente; Gema Esquiva
Journal:  Biomedicines       Date:  2021-03-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.